| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.23 | 7e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |